Agilon Health, Inc. AGL
Institutional shares held
355 Million
2.64M
calls
1.9M
puts
Total value of holdings
$1.54B
$11.4M
calls
$8.24M
puts
Market Cap
$1.78B
410,936,000
Shares Out.
Institutional ownership
86.43%
# of Institutions
218
We take great care to ensure that the data presented and summarized in this overview for agilon health, inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AGL
View all-
Clayton, Dubilier & Rice, LLC100MShares$433 Million98.65% of portfolio
-
Morgan Stanley New York, NY56.2MShares$244 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$201 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA31.1MShares$135 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$101 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA22.3MShares$96.7 Million0.01% of portfolio
-
State Street Corp Boston, MA7.76MShares$33.6 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD7.46MShares$32.3 Million0.57% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny7.21MShares$31.2 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA6.93MShares$30 Million0.0% of portfolio
Latest Institutional Activity in AGL
Top Purchases
Top Sells
About AGL
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Insider Transactions at AGL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2025
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
551,471
+37.82%
|
-
|
|
Apr 01
2025
|
Timothy Gertsch Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,275
+33.98%
|
-
|
|
Apr 01
2025
|
Benjamin Shaker Chief Markets Officer |
BUY
Grant, award, or other acquisition
|
Direct |
428,922
+32.62%
|
-
|
|
Apr 01
2025
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122,550
+30.62%
|
-
|
|
Apr 01
2025
|
Denise Zamore Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
245,099
+35.26%
|
-
|
|
Mar 14
2025
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,311
-2.09%
|
$13,244
$4.05 P/Share
|
|
Mar 14
2025
|
Girish Venkatachaliah Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
9,429
+5.62%
|
-
|
|
Mar 14
2025
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,143
-0.9%
|
$16,572
$4.05 P/Share
|
|
Mar 14
2025
|
Benjamin Shaker Chief Markets Officer |
BUY
Open market or private purchase
|
Direct |
11,786
+2.49%
|
-
|
|
Mar 14
2025
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
15,563
-4.2%
|
$62,252
$4.05 P/Share
|
|
Mar 14
2025
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Direct |
42,426
+10.27%
|
-
|
|
Dec 13
2024
|
Karen Mc Loughlin Director |
BUY
Open market or private purchase
|
Direct |
25,000
+25.47%
|
$50,000
$2.2 P/Share
|
|
Dec 11
2024
|
Silvana Battaglia Director |
BUY
Open market or private purchase
|
Direct |
25,062
+27.48%
|
$50,124
$2.01 P/Share
|
|
Dec 09
2024
|
Diana Mckenzie Director |
BUY
Open market or private purchase
|
Direct |
7,500
+11.31%
|
$15,000
$2.2 P/Share
|
|
Dec 05
2024
|
John William Wulf Director |
BUY
Open market or private purchase
|
Direct |
45,000
+17.92%
|
$90,000
$2.18 P/Share
|
|
Nov 25
2024
|
Diana Mckenzie Director |
BUY
Open market or private purchase
|
Direct |
12,500
+19.59%
|
$25,000
$2.28 P/Share
|
|
Sep 12
2024
|
Steven Sell CEO & President |
BUY
Open market or private purchase
|
Indirect |
20,000
+22.83%
|
$60,000
$3.36 P/Share
|
|
Aug 16
2024
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
405
-0.69%
|
$1,620
$4.85 P/Share
|
|
Jul 01
2024
|
Jeffrey A. Schwaneke Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
659,880
+27.35%
|
-
|
|
May 29
2024
|
Silvana Battaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
32,119
+43.88%
|
-
|
Last 12 Months Summary
Buy / Acquisition
3.29M
Shares
From
20
Insiders
| Grant, award, or other acquisition | 3.09M shares |
|---|---|
| Open market or private purchase | 199K shares |
Sell / Disposition
49.7K
Shares
From
6
Insiders
| Payment of exercise price or tax liability | 49.7K shares |
|---|